Webinars / Podcasts
Webinar
Strategic Considerations for a Successful CNS Clinical Development Pathway
Central Nervous System (CNS) drug evaluation requires the assessment of specific safety endpoints, such as the drug’s potential to cause impairing effects on driving, the likelihood that it may be abused or misused, or the risk of causing withdrawal symptoms if abruptly discontinued.
Webinar
SOT Virtual Poster Session
Get the most of Altasciences’ preclinical NHP expertise by attending two sessions.
Webinar
Bioanalysis by Hybridization ELISA for Antisense Oligonucleotides
How hybridization ELISA can be an effective approach to quantify antisense oligonucleotides in circulation and in their targeted tissue.
Webinar
Cracking the pill: A journey of exploring abuse deterrent methods from the laboratory, clinic, and to the real user
The evolving laboratory and clinical methods, as they apply to both opioids and stimulants. Included is a rare candid interview with recreational drug users that will provide you with a direct, unique perspective.
Webinar
Harnessing Bioanalytical Data in Early Phase Clinical Pharmacology
A discussion on how bioanalytical data is used in early phase clinical trials to advance drug development.